Current listed pricePKR 89,946.12Effective 2026-07-27
Product details
- Generic
- Bevacizumab
- Therapeutic class
- —
- ATC
- —
- Strength
- 400 mg/16 mL (25 mg/mL)
- Dosage form
- Injection / infusion
- Pack
- 1's
- Registration no.
- 107970
- Verification
- 2026-08-07
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →Traceability
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 89,946.12 | 2026-07-27 | 2026-08-07 | DRAP PharmaPrice Index | Current |
Same generic
Alternative listed brands
ABEVMY 100 mg/4 mLAGP Limited · PKR 25,715.62Abevmy 400 400 mg/16 mL (25 mg/mL)AGP Limited · PKR 102,238.25Arketin 100 mg/4 mLRA Healthcare (SMC-Pvt) Ltd · PKR 17,674.07Avastin 400 mg/16 mLRoche Pakistan Ltd · PKR 236,486.52Avastin 100 mg/4 mLRoche Pakistan Ltd · PKR 59,483.08BAZUMAB 100 mg/4 mLHilton Pharma (Pvt) Limited. · PKR 23,067.95BAZUMAB 400 mg/16 mLHilton Pharma (Pvt) Limited. · PKR 91,711.79Bevec 400 mg/16 mL (25 mg/mL)PHARMEVO (PVT) LTD. · PKR 102,238.25
Price note: MedInfoBase displays source-listed prices where available. A pharmacy's transaction price may differ. Verify current regulatory and product information before professional use.